AzTrials
AzTrials

Heart FailureNEHFNCT02425488

Nursing Therapeutics Education and Heart Failure (HF): a Study Protocol

A study testing Nursing therapeutics education in people with Heart Failure and Arrhythmia, run by University of Turin, Italy at 2 sites in Italy.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias for which international guidelines suggest the implantation of an implantable cardiac defibrillator (ICD). Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Heart Failure, Arrhythmia
What is being tested?
Nursing therapeutics education
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
2 sitesItaly
Study dates
Apr 2015to Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
  • Patients who have given written consent for the research.

Who cannot join

  • Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
  • Minors.

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • Cardiovascular Department, Rivoli Hospital, ASL TO3

    Rivoli, Turin, 10098

  • Cardiovascular Department, Città della Salute e della Scienza, University Hospital

    Turin, 100126

Other trials in Italy

About this study

Official title: Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study

Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias for which international guidelines suggest the implantation of an implantable cardiac defibrillator (ICD). The educational nursing program would improve clinical outcomes in patients with HF and ICD like control their sickness, known and acknowledge symptoms, improve their skills to self-care.

The main aim of this study is to assess how much the nursing-therapeutics skills and an educational intervention, in patients with HF during the follow-up period after the implantation of ICD reduces clinical costs, re-hospitalizations, and mortality at 180 days.

Read more

Methods: The investigators start a multicenter randomized clinical trial. The sample is made of 128 subjects (64 patients treatment group and 64 control group). The investigators measured the self-care level administering to HF patients the "Self-Care of Heart Failure Index (SCHFI) v. 6.2", and the self-perception of own life quality using a Numeric Rating Scale from 0 to 100. Secondary outcomes recorded are i) the numbers of accesses to the ED (Emergency Department) and/or hospitalizations during the follow-up period, ii) mortality rate due to HF, and iii) infection rate of the device pocket.

Data Analysis: Categorical variables will be presented in terms of frequencies and percentages. The statistical power was fixed at the 80%. Data will be considered significant for a p-value ≤ 0.05. The Cox proportional hazards model will be used to analyze mortality in subjects involved in the educational program.

Read the detailed description

Aims of the study The aim of this study is to examine the effects of a nursing intervention consisting of sanitary-therapeutic education during the follow-up period after the implantation of a defibrillator (ICD) in patients with congestive heart failure.

The effectiveness of the educational intervention will be assessed on the basis of the level of "self-care" in every individual and their lifestyle as well as on mortality rates, readmission to the hospital and ICD pocket infection.

Educational intervention will focus on

  1. Appropriate lifestyles
  2. Early recognition of signs/prodromal symptoms of HF
  3. Early recognition of signs of inflammation of the ICD-pocket
  4. Good management of the device

<!-- -->

  1. Therapy, body weight, diet, smoking, alcohol, rest, exercise, job, and sex
  2. Dyspnea, edema, and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion
  3. Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor
  4. Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI Materials and methods A multicenter randomized controlled study will be performed. The research project will involve two clinical centers in northern Italy: the "Città della Salute e della Scienza" University Hospital of Turin, which includes the "Molinette" Hospital (coordinator center), and the TO3 ASL, which includes the "Associated Hospitals of Rivoli". Subject recruitment and data collection will take place until data saturation is achieved, with an estimated period of approximately 12 months from the beginning of the study. Participants Inclusion criteria:
  • Patients affected by heart failure following elective hospitalization during which an ICD was implanted on an arrhythmic and/or ischemic basis.
  • Patients who have given written consent for the research. Exclusion criteria:
  • Patients with syndromes and diseases that compromise their understanding of information, learning and all cognitive activities in general.
  • Minors. Primary outcome measures • Self-care levels (measured using the Self-Care Heart Failure Index, SCHFI v 6.2)
  • Quality of life perception (measured using a numerical rating scale from 0 to 100) Secondary outcome measures • Number of visits to the ED (Emergency Department) and/or hospitalizations during the follow-up period after the implantation of a defibrillator (ICD).
  • Mortality rate at 180 days after the implantation of the ICD due to HF-related causes.
  • Infection rate in the device pocket. Data, sources and collection tools • Socio-demographic and clinical data: For all of the included patients, demographic (gender, age, educational level, marital status, country of birth (Italian citizens or foreigners), social (through a family context survey) and clinical (classification of HF using the NYHA classification, the implantation date and type of ICD, the execution of and the changes in laboratory tests and electrocardiograms results, number of perceived discharges) data will be recorded. Data on the patient's diagnosis and possible associated diseases will be obtained through the analysis of clinical documentation and will be record in accordance with the International Statistical Classification of Diseases and Related Health Problems, 9th Revision (ICD-IX).
  • Economic data: For patients included in the study, the following data will be collected:
  • economic activity, occupational qualifications (if employed/ex-employed);
  • visits to the ED and/or hospitalizations during the follow-up period, verified through analysis of administrative documentation certifying visits and admissions (Verbal First Aid and Medical record);
  • the presence of a companion for the patients during their stay in the ED or hospital as well as their economic activity and professional qualifications;
  • any costs directly incurred by the patient or companion;
  • time spent by the nursing figure in providing therapeutic education. From society's point of view, the benefits received in the ED and hospitalizations will be assessed according to the charge currently in force in Italy. Indirect costs, represented by the time spent by the patient, and costs related to the time spent by caregivers will be valorized using values published by official sources such as ISTAT. Costs directly charged to the patient will be valued on the basis of the stated cost. Finally, the cost of time spent in educational activities will be assessed using the hourly average cost of a nurse and/or doctor in the clinical centers that participate in this study.
  • Self-Care Heart Failure Index (SCHFI) version 6.2. A tool validated in the Italian context that allows evaluation of a patient's awareness and capacity for self-care11. The obtained responses are organized on a four-level Likert scale (1 = never, 4 = every day). Specifically, this instrument is divided into three sections: Section A: (questions 1 to 10) investigates self-care skills; Section B: (questions 11 to 16) investigates an individual's symptomatology recognition skills; Section C: (questions 17 to 22) investigates the self-confidence related to self-care skills in detail. The total score is computed in the following manner: Section A: 10 is subtracted from the sum of the section results considering answers 1 to 10, and the result is multiplied by a coefficient of 3.33; Section B: 4 is subtracted from sum of the section results considering answers 11 to 16, and the result is multiplied by a coefficient of 5; Section C: 6 is subtracted from sum of the section results considering answers 17 to 22, and the result is multiplied by a coefficient of 5.56 All of the results have to be considered in terms of percentages. If the percentages for individual sections are all higher than the cut-off value (70%), then according to the literature11, the level of self-care is considered adequate. Otherwise, for lower values, the section showing an insufficient result will be strengthened.
  • Numeric Rating Scale: scale from 0 to 100 used for subjective measurement of the perceived quality of life. This tool will be evaluated by a committee of experts using a pre-test, which is currently under way.
Being tested
Nursing therapeutics education
Keywords
Nursing, Outcome and Process Assessment, Cardiac Resynchronization Therapy Devices, Heart Failure, Education
Medical subject headings
Heart Failure, Arrhythmias, Cardiac

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nursing therapeutics educationBehavioural

    Educational intervention will focus on

    1. Appropriate lifestyles
    2. Early recognition of signs/prodromal symptoms of HF
    3. Early recognition of signs of inflammation of the ICD-pocket
    4. Good management of the device
    5. Therapy, body weight, diet, smoking, alcohol, rest, exercise, job and sex 2) Dyspnea, edema and fovea, rapid weight gain, loss of appetite, fatigue, asthenia, insomnia, mental confusion 3) Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor 4) Identification tag, vibration, metal detectors, air travel, use of electronic devices, diagnostic PET and MRI
Study groups in NCT02425488
Study groupRoleWhat they receive
Nursing therapeutics educationExperimentalPeople who are educated by the nurse (Behavioral intervention: Nursing therapeutics education) and follow all the program (12 months)
Receives: Behavioral: Nursing therapeutics education
Non NETNo interventionPeople who receive basic information without follow the educational program but clinically controlled

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-care levels (Self-Care Heart Failure Index (SCHFI) version 6.2)

    Increase of the Self Care competence, management and confidence with heart failure and the cardiac device

    Measured: 12 months

Secondary outcomes (4)
  1. Quality life perception

    Increase in quality of life due to the development of management skills with heart disease

    Measured: 12 months

  2. Visits to the ED

    Number of visits to the ED (Emergency Department) and/or hospitalizations during the follow-up period after the implantation of a defibrillator (ICD).

    Measured: 12 months

  3. Mortality

    Mortality rate at 180 days after the implantation of the ICD due to HF-related causes

    Measured: 180 days

  4. Infection

    Infection rate in the device pocket.

    Measured: 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Apr 2015 (estimated)
  2. Study startApr 2015
  3. Primary completion29 Oct 2017
  4. Study completionApr 2018

Why it stopped: Feasability phase completed: Cost Evaluation

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02425488
Sponsor's protocol ID
HFICD
Acronym
NEHF
Status last verified
May 2018
First submitted
20 Apr 2015
Last updated
7 May 2018
Results posted
No
Data monitoring committee
Yes
Individual data sharing
No

Publications

  • Hickey A, Barker M, McGee H, O'Boyle C. Measuring health-related quality of life in older patient populations: a review of current approaches. Pharmacoeconomics. 2005;23(10):971-93. doi: 10.2165/00019053-200523100-00002.

    PubMed 16235972
  • Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-83. doi: 10.1056/NEJMoa013474. Epub 2002 Mar 19.

    PubMed 11907286
  • Pulignano G, Del Sindaco D, Minardi G, Tarantini L, Cioffi G, Bernardi L, Di Biagio D, Leonetti S, Giovannini E. Translation and validation of the Italian version of the European Heart Failure Self-care Behaviour Scale. J Cardiovasc Med (Hagerstown). 2010 Jul;11(7):493-8. doi: 10.2459/JCM.0b013e328335fbf5.

    PubMed 20407384
  • Stromberg A. Educating nurses and patients to manage heart failure. Eur J Cardiovasc Nurs. 2002 Feb;1(1):33-40. doi: 10.1016/S1474-5151(01)00011-1.

    PubMed 14622865
  • Aspromonte N, Di Tano G, Latini R, Masson S, Valle R, Emdin M. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients]. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 2):17S-23S. Italian.

    PubMed 20873464
  • MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A, Redpath A, Pell JP, McMurray JJ. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000 Sep 5;102(10):1126-31. doi: 10.1161/01.cir.102.10.1126.

    PubMed 10973841
  • Cocchieri A, Riegel B, D'Agostino F, Rocco G, Fida R, Alvaro R, Vellone E. Describing self-care in Italian adults with heart failure and identifying determinants of poor self-care. Eur J Cardiovasc Nurs. 2015 Apr;14(2):126-36. doi: 10.1177/1474515113518443. Epub 2013 Dec 23.

    PubMed 24366984

Questions about this trial

What is this clinical trial studying?

A study testing Nursing therapeutics education in people with Heart Failure and Arrhythmia, run by University of Turin, Italy at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 7 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Feasability phase completed: Cost Evaluation). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-care levels (Self-Care Heart Failure Index (SCHFI) version 6.2) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02425488, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in